Literature DB >> 27756485

A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.

T Hertz1, M G Logan2, M Rolland3, C A Magaret1, C Rademeyer2, A Fiore-Gartland1, P T Edlefsen1, A DeCamp1, H Ahmed1, N Ngandu2, B B Larsen4, N Frahm1, J Marais2, R Thebus2, D Geraghty5, J Hural1, L Corey1, J Kublin1, G Gray6,7,1, M J McElrath1, J I Mullins4, P B Gilbert1, C Williamson2,8.   

Abstract

INTRODUCTION: The Merck Adenovirus-5 Gag/Pol/Nef HIV-1 subtype-B vaccine evaluated in predominately subtype B epidemic regions (Step Study), while not preventing infection, exerted vaccine-induced immune pressure on HIV-1 breakthrough infections. Here we investigated if the same vaccine exerted immune pressure when tested in the Phambili Phase 2b study in a subtype C epidemic.
MATERIALS AND METHODS: A sieve analysis, which compares breakthrough viruses from placebo and vaccine arms, was performed on 277 near full-length genomes generated from 23 vaccine and 20 placebo recipients. Vaccine coverage was estimated by computing the percentage of 9-mers that were exact matches to the vaccine insert.
RESULTS: There was significantly greater protein distances from the vaccine immunogen sequence in Gag (p=0.045) and Nef (p=0.021) in viruses infecting vaccine recipients compared to placebo recipients. Twenty-seven putative sites of vaccine-induced pressure were identified (p<0.05) in Gag (n=10), Pol (n=7) and Nef (n=10), although they did not remain significant after adjustment for multiple comparisons. We found the epitope sieve effect in Step was driven by HLA A∗02:01; an allele which was found in low frequency in Phambili participants compared to Step participants. Furthermore, the coverage of the vaccine against subtype C Phambili viruses was 31%, 46% and 14% for Gag, Pol and Nef, respectively, compared to subtype B Step virus coverage of 56%, 61% and 26%, respectively. DISCUSSION: This study presents evidence of sieve effects in Gag and Nef; however could not confirm effects on specific amino acid sites. We propose that this weaker signal of vaccine immune pressure detected in the Phambili study compared to the Step study may have been influenced by differences in host genetics (HLA allele frequency) and reduced impact of vaccine-induced immune responses due to mismatch between the viral subtype in the vaccine and infecting subtypes.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIV-1 vaccine; HVTN-503; Phambili; Sieve analysis; Step

Mesh:

Substances:

Year:  2016        PMID: 27756485      PMCID: PMC5309337          DOI: 10.1016/j.vaccine.2016.09.054

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Genome scanning tests for comparing amino acid sequences between groups.

Authors:  Peter B Gilbert; Chunyuan Wu; David V Jobes
Journal:  Biometrics       Date:  2007-06-30       Impact factor: 2.571

2.  Web-based design and evaluation of T-cell vaccine candidates.

Authors:  James Thurmond; Hyejin Yoon; Carla Kuiken; Karina Yusim; Simon Perkins; James Theiler; Tanmoy Bhattacharya; Bette Korber; Will Fischer
Journal:  Bioinformatics       Date:  2008-05-29       Impact factor: 6.937

3.  New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids.

Authors:  M Sandberg; L Eriksson; J Jonsson; M Sjöström; S Wold
Journal:  J Med Chem       Date:  1998-07-02       Impact factor: 7.446

4.  Peptide quantitative structure-activity relationships, a multivariate approach.

Authors:  S Hellberg; M Sjöström; B Skagerberg; S Wold
Journal:  J Med Chem       Date:  1987-07       Impact factor: 7.446

5.  DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites.

Authors:  Wenjie Deng; Brandon S Maust; David C Nickle; Gerald H Learn; Yi Liu; Laura Heath; Sergei L Kosakovsky Pond; James I Mullins
Journal:  Biotechniques       Date:  2010-05       Impact factor: 1.993

Review 6.  Sieve analysis in HIV-1 vaccine efficacy trials.

Authors:  Paul T Edlefsen; Peter B Gilbert; Morgane Rolland
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283

7.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

8.  Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants.

Authors:  M-R Abrahams; J A Anderson; E E Giorgi; C Seoighe; K Mlisana; L-H Ping; G S Athreya; F K Treurnicht; B F Keele; N Wood; J F Salazar-Gonzalez; T Bhattacharya; H Chu; I Hoffman; S Galvin; C Mapanje; P Kazembe; R Thebus; S Fiscus; W Hide; M S Cohen; S Abdool Karim; B F Haynes; G M Shaw; B H Hahn; B T Korber; R Swanstrom; C Williamson
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

9.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Authors:  Morgane Rolland; Sodsai Tovanabutra; Allan C deCamp; Nicole Frahm; Peter B Gilbert; Eric Sanders-Buell; Laura Heath; Craig A Magaret; Meera Bose; Andrea Bradfield; Annemarie O'Sullivan; Jacqueline Crossler; Teresa Jones; Marty Nau; Kim Wong; Hong Zhao; Dana N Raugi; Stephanie Sorensen; Julia N Stoddard; Brandon S Maust; Wenjie Deng; John Hural; Sheri Dubey; Nelson L Michael; John Shiver; Lawrence Corey; Fusheng Li; Steve G Self; Jerome Kim; Susan Buchbinder; Danilo R Casimiro; Michael N Robertson; Ann Duerr; M Juliana McElrath; Francine E McCutchan; James I Mullins
Journal:  Nat Med       Date:  2011-02-27       Impact factor: 53.440

10.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.

Authors:  Morgane Rolland; Paul T Edlefsen; Brendan B Larsen; Sodsai Tovanabutra; Eric Sanders-Buell; Tomer Hertz; Allan C deCamp; Chris Carrico; Sergey Menis; Craig A Magaret; Hasan Ahmed; Michal Juraska; Lennie Chen; Philip Konopa; Snehal Nariya; Julia N Stoddard; Kim Wong; Hong Zhao; Wenjie Deng; Brandon S Maust; Meera Bose; Shana Howell; Adam Bates; Michelle Lazzaro; Annemarie O'Sullivan; Esther Lei; Andrea Bradfield; Grace Ibitamuno; Vatcharain Assawadarachai; Robert J O'Connell; Mark S deSouza; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Merlin L Robb; Jason S McLellan; Ivelin Georgiev; Peter D Kwong; Jonathan M Carlson; Nelson L Michael; William R Schief; Peter B Gilbert; James I Mullins; Jerome H Kim
Journal:  Nature       Date:  2012-09-10       Impact factor: 49.962

View more
  11 in total

1.  Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization.

Authors:  H-X Tan; A K Wheatley; R Esterbauer; S Jegaskanda; J J Glass; D Masopust; R De Rose; S J Kent
Journal:  Mucosal Immunol       Date:  2017-10-25       Impact factor: 7.313

Review 2.  Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.

Authors:  Kathryn E Stephenson; Kshitij Wagh; Bette Korber; Dan H Barouch
Journal:  Annu Rev Immunol       Date:  2020-04-26       Impact factor: 32.481

3.  Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

Authors:  Allan C deCamp; Morgane Rolland; Paul T Edlefsen; Eric Sanders-Buell; Breana Hall; Craig A Magaret; Andrew J Fiore-Gartland; Michal Juraska; Lindsay N Carpp; Shelly T Karuna; Meera Bose; Steven LePore; Shana Miller; Annemarie O'Sullivan; Kultida Poltavee; Hongjun Bai; Kalpana Dommaraju; Hong Zhao; Kim Wong; Lennie Chen; Hasan Ahmed; Derrick Goodman; Matthew Z Tay; Raphael Gottardo; Richard A Koup; Robert Bailer; John R Mascola; Barney S Graham; Mario Roederer; Robert J O'Connell; Nelson L Michael; Merlin L Robb; Elizabeth Adams; Patricia D'Souza; James Kublin; Lawrence Corey; Daniel E Geraghty; Nicole Frahm; Georgia D Tomaras; M Juliana McElrath; Lisa Frenkel; Sheila Styrchak; Sodsai Tovanabutra; Magdalena E Sobieszczyk; Scott M Hammer; Jerome H Kim; James I Mullins; Peter B Gilbert
Journal:  PLoS One       Date:  2017-11-17       Impact factor: 3.240

4.  Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features.

Authors:  Craig A Magaret; David C Benkeser; Brian D Williamson; Bhavesh R Borate; Lindsay N Carpp; Ivelin S Georgiev; Ian Setliff; Adam S Dingens; Noah Simon; Marco Carone; Christopher Simpkins; David Montefiori; Galit Alter; Wen-Han Yu; Michal Juraska; Paul T Edlefsen; Shelly Karuna; Nyaradzo M Mgodi; Srilatha Edugupanti; Peter B Gilbert
Journal:  PLoS Comput Biol       Date:  2019-04-01       Impact factor: 4.475

5.  Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy Assessment.

Authors:  Raabya Rossenkhan; Morgane Rolland; Jan P L Labuschagne; Roux-Cil Ferreira; Craig A Magaret; Lindsay N Carpp; Frederick A Matsen Iv; Yunda Huang; Erika E Rudnicki; Yuanyuan Zhang; Nonkululeko Ndabambi; Murray Logan; Ted Holzman; Melissa-Rose Abrahams; Colin Anthony; Sodsai Tovanabutra; Christopher Warth; Gordon Botha; David Matten; Sorachai Nitayaphan; Hannah Kibuuka; Fred K Sawe; Denis Chopera; Leigh Anne Eller; Simon Travers; Merlin L Robb; Carolyn Williamson; Peter B Gilbert; Paul T Edlefsen
Journal:  Viruses       Date:  2019-07-03       Impact factor: 5.048

6.  Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.

Authors:  Morgane Rolland; Sodsai Tovanabutra; Bethany Dearlove; Yifan Li; Christopher L Owen; Eric Lewitus; Eric Sanders-Buell; Meera Bose; AnneMarie O'Sullivan; Raabya Rossenkhan; Jan Phillipus Lourens Labuschagne; Paul T Edlefsen; Daniel B Reeves; Gustavo Kijak; Shana Miller; Kultida Poltavee; Jenica Lee; Lydia Bonar; Elizabeth Harbolick; Bahar Ahani; Phuc Pham; Hannah Kibuuka; Lucas Maganga; Sorachai Nitayaphan; Fred K Sawe; Leigh Anne Eller; Robert Gramzinski; Jerome H Kim; Nelson L Michael; Merlin L Robb
Journal:  PLoS Pathog       Date:  2020-02-06       Impact factor: 6.823

7.  Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.

Authors:  Glenda E Gray; Linda-Gail Bekker; Fatima Laher; Mookho Malahleha; Mary Allen; Zoe Moodie; Nicole Grunenberg; Yunda Huang; Doug Grove; Brittany Prigmore; Jia J Kee; David Benkeser; John Hural; Craig Innes; Erica Lazarus; Graeme Meintjes; Nivashnee Naicker; Dishiki Kalonji; Maphoshane Nchabeleng; Modulakgotla Sebe; Nishanta Singh; Philip Kotze; Sheetal Kassim; Thozama Dubula; Vimla Naicker; William Brumskine; Cleon N Ncayiya; Amy M Ward; Nigel Garrett; Girisha Kistnasami; Zakir Gaffoor; Pearl Selepe; Philisiwe B Makhoba; Matsontso P Mathebula; Pamela Mda; Tania Adonis; Katlego S Mapetla; Bontle Modibedi; Tricia Philip; Gladys Kobane; Carter Bentley; Shelly Ramirez; Simbarashe Takuva; Megan Jones; Mpho Sikhosana; Millicent Atujuna; Michele Andrasik; Nima S Hejazi; Adrian Puren; Lubbe Wiesner; Sanjay Phogat; Carlos Diaz Granados; Marguerite Koutsoukos; Olivier Van Der Meeren; Susan W Barnett; Niranjan Kanesa-Thasan; James G Kublin; M Juliana McElrath; Peter B Gilbert; Holly Janes; Lawrence Corey
Journal:  N Engl J Med       Date:  2021-03-25       Impact factor: 91.245

8.  AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period.

Authors:  Yunda Huang; Kelly E Seaton; Martin Casapia; Laura Polakowski; Stephen C De Rosa; Kristen Cohen; Chenchen Yu; Marnie Elizaga; Carmen Paez; Maurine D Miner; Colleen F Kelley; Janine Maenza; Michael Keefer; Javier R Lama; Magdalena Sobieszczyk; Susan Buchbinder; Lindsey R Baden; Carter Lee; Vineeta Gulati; Faruk Sinangil; David Montefiori; M Juliana McElrath; Georgia D Tomaras; Harriet L Robinson; Paul Goepfert
Journal:  Vaccine       Date:  2021-07-03       Impact factor: 4.169

9.  SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials.

Authors:  Andrew Fiore-Gartland; Nicholas Kullman; Allan C deCamp; Graham Clenaghan; Wayne Yang; Craig A Magaret; Paul T Edlefsen; Peter B Gilbert
Journal:  Bioinformatics       Date:  2017-08-01       Impact factor: 6.937

10.  T cell-based strategies for HIV-1 vaccines.

Authors:  Bette Korber; Will Fischer
Journal:  Hum Vaccin Immunother       Date:  2019-10-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.